Coherus BioSciences (CHRS) Defended at Citi, Analyst Says Buy Weakness - Bloomberg

November 7, 2016 1:20 PM EST
Get Alerts CHRS Hot Sheet
Price: $27.85 +1.27%

Rating Summary:
    8 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 21 | Down: 18 | New: 19
Trade CHRS Now!
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Coherus BioSciences (NASDAQ: CHRS) Defended at Citi, Analyst Says Buy Weakness - Bloomberg



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Analyst Comments, Hot Comments, Trader Talk

Related Entities

Citi

Add Your Comment